D
Market Data
$28.18−$0.81 (−2.79%)
DMRA · Last trade
Prev Close
$28.99
Range (30d)
$28.14 – $32.44
Recent Filings
- 10-Q12.5 MBDamora Therapeutics, Inc.Aug 10, 4:00 PM ET·0001193125-26-342307
- 1446.4 KBDamora Therapeutics, Inc.Aug 6, 11:34 AM ET·0001970051-26-000018
- SCHEDULE 13G11.1 KBDamora Therapeutics, Inc.Jul 28, 4:44 PM ET·0002012383-26-002507
- 8-K1.2 MBDamora Therapeutics, Inc.Jul 20, 4:00 PM ET·0001193125-26-308899
- 8-K212.5 KBDamora Therapeutics, Inc.Jun 17, 4:00 PM ET·0001193125-26-274093
- 10-Q9.2 MBDamora Therapeutics, Inc.May 12, 4:00 PM ET·0001193125-26-219327
- 8-K183.3 KBDamora Therapeutics, Inc.May 4, 4:00 PM ET·0001193125-26-203913
- 8-K197.3 KBDamora Therapeutics, Inc.Apr 20, 4:00 PM ET·0001193125-26-163909
- 8-K521.9 KBDamora Therapeutics, Inc.Mar 23, 9:00 AM ET·0001193125-26-118699
- 10-K16.0 MBDamora Therapeutics, Inc.Mar 19, 4:00 PM ET·0001193125-26-115922
Insiders
10- Bruno JulianneDirector
- Burkavage BrianSVP, Finance
- CAIN CHRISTOPHER W.Director
- Cheng AndrewDirector
- Christgau StephanDirector
- Dallas Jayson Donald AlexanderDirector
- Fairmount Funds Management LLCDirector, 10% Owner
- Fairmount Healthcare Fund II L.P.Director, 10% Owner
- Firmani LoriChief Financial Officer
- Freve JonathanChief Financial Officer
Tickers
Addresses
business
221 CRESCENT STREET BUILDING 23, SUITE 105
WALTHAM, MA, 02453
mailing
221 CRESCENT STREET BUILDING 23, SUITE 105
WALTHAM, MA, 02453
Former Names
- Galecto, Inc.2026-03-10
- Galecto Inc.2020-10-28